Table 3—

Prevalence of the metabolic syndrome using the ATP III and WHO criteria among 2,857 U.S. adults aged 40–74 years who had an oral glucose tolerance test (NHANES III, 1988–1994)

Age-adjusted
Unadjusted
ATP IIIWHOAgreement*ATP III = yes, WHO = noWHO = yes, ATP III = no
Total33.9 ± 1.536.9 ± 1.581.9 ± 1.17.6 ± 0.610.5 ± 0.9
Men34.8 ± 2.041.3 ± 2.380.9 ± 1.76.4 ± 1.112.8 ± 1.3
Women33.0 ± 1.932.7 ± 1.882.9 ± 1.38.8 ± 0.78.4 ± 1.1
Race or ethnicity
 White34.6 ± 1.835.9 ± 1.682.2 ± 1.28.4 ± 0.89.4 ± 0.9
 African-American29.5 ± 1.937.5 ± 2.280.0 ± 1.46.1 ± 0.913.9 ± 1.1
 Mexican-American45.5 ± 2.053.0 ± 2.078.8 ± 2.37.0 ± 1.314.2 ± 1.7
 Other24.1 ± 4.935.9 ± 4.781.8 ± 4.41.4 ± 0.816.9 ± 4.5
Men
 White36.4 ± 2.541.0 ± 2.481.6 ± 1.87.2 ± 1.311.2 ± 1.4
 African-American21.6 ± 2.635.3 ± 2.977.9 ± 2.04.1 ± 1.318.0 ± 1.6
 Mexican-American39.4 ± 2.848.4 ± 2.680.6 ± 3.35.9 ± 1.713.5 ± 2.6
 Other27.8 ± 6.943.7 ± 6.076.3 ± 7.10.6 ± 0.623.1 ± 7.1
Women
 White32.9 ± 2.131.2 ± 2.082.9 ± 1.59.5 ± 0.87.6 ± 1.2
 African-American35.8 ± 2.939.4 ± 3.381.6 ± 1.87.6 ± 1.210.8 ± 1.5
 Mexican-American51.9 ± 2.858.3 ± 3.576.9 ± 2.88.2 ± 1.715.0 ± 2.1
 Other21.4 ± 6.028.2 ± 5.687.3 ± 4.42.1 ± 1.710.6 ± 5.0
  • Data are % ± SE except the difference.

  • *

    * Percent of participants who were classified as either having or not having the metabolic syndrome under both definitions of the metabolic syndrome.